Literature DB >> 33411177

Guideline-led prescribing to ambulatory heart failure patients in a cardiology outpatient service.

Seif El Hadidi1,2, Carl Vaughan3, David Kerins3,4, Stephen Byrne1, Ebtissam Darweesh2, Margaret Bermingham5.   

Abstract

Background Guidelines recommend heart failure (HF) patients be treated with multiple medications at doses proven to improve clinical outcomes. Objective To study guideline-led prescribing in an Irish outpatient HF population. Setting Cardiology Outpatient Clinic, Mercy University Hospital, Cork, Ireland. Methods Guideline-led prescribing was assessed using the Guideline Adherence Index (GAI-3), that considered the prescribing of ACE inhibitors and angiotensin receptor blockers; beta-blockers and mineralocorticoid receptor antagonists. The GAI-based target dose was calculated based on the prescription of ≥ 50% of the guideline-recommended target dose of each of the three GAI medications to HF patients with ejection fraction ≤ 40%. High-GAI was achieved by prescription of ≥ 2 GAI medicines. Potentially inappropriate prescribing was assessed using a HF-specific tool. Main outcome measure Heart failure guideline-led prescribing assessed using the GAI-3. Results A total of 127 HF patients, mean age 71.7 ± 13.1 years, were identified in the study. Seventy-one patients had ejection fraction ≤ 40%. Population mean GAI-3 was 65.8%. When contraindications to therapy are considered, the adjusted GAI-3 increased to 72.9%. The target dose GAI was 18.5%. High-GAI management was prescribed to 54 patients (76.1%). A potentially inappropriate medicine in HF was prescribed to 14 (19.7%) patients. Conclusion Most HF patients with ejection fraction ≤ 40% in this setting received optimal guideline-led prescribing however the proportion of patients achieving the target doses of these agents was suboptimal.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG part of Springer Nature.

Entities:  

Keywords:  Beta-blockers; Guideline adherence index; Guideline-directed medical therapies; Guideline-led prescribing; Heart failure; Inappropriate prescribing; Renin-angiotensin system

Year:  2021        PMID: 33411177     DOI: 10.1007/s11096-020-01220-z

Source DB:  PubMed          Journal:  Int J Clin Pharm


  41 in total

Review 1.  Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges.

Authors:  Catherine N Marti; Gregg C Fonarow; Stefan D Anker; Clyde Yancy; Muthiah Vaduganathan; Stephen J Greene; Ali Ahmed; James L Januzzi; Mihai Gheorghiade; Gerasimos Filippatos; Javed Butler
Journal:  Eur J Heart Fail       Date:  2018-12-10       Impact factor: 15.534

2.  Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.

Authors:  Michel Komajda; Martin R Cowie; Luigi Tavazzi; Piotr Ponikowski; Stefan D Anker; Gerasimos S Filippatos
Journal:  Eur J Heart Fail       Date:  2017-04-30       Impact factor: 15.534

3.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher
Journal:  Eur Heart J       Date:  2012-05-19       Impact factor: 29.983

4.  Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.

Authors:  Stephen J Greene; Javed Butler; Nancy M Albert; Adam D DeVore; Puza P Sharma; Carol I Duffy; C Larry Hill; Kevin McCague; Xiaojuan Mi; J Herbert Patterson; John A Spertus; Laine Thomas; Fredonia B Williams; Adrian F Hernandez; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2018-07-24       Impact factor: 24.094

5.  Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups.

Authors:  Ulrik Madvig Mogensen; Mads Ersbøll; Mads Andersen; Charlotte Andersson; Christian Hassager; Christian Torp-Pedersen; Finn Gustafsson; Lars Køber
Journal:  Eur J Heart Fail       Date:  2011-09-06       Impact factor: 15.534

6.  Discontinuation of beta-blockers in cardiovascular disease: UK primary care cohort study.

Authors:  Paul R Kalra; Chris Morley; Susie Barnes; Ian Menown; George Kassianos; Sandosh Padmanabhan; Sandeep Gupta; Chim C Lang
Journal:  Int J Cardiol       Date:  2012-07-26       Impact factor: 4.164

7.  Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study.

Authors:  W Ouwerkerk; A A Voors; S D Anker; J G Cleland; K Dickstein; G Filippatos; P van der Harst; H L Hillege; C C Lang; J M Ter Maaten; L L Ng; P Ponikowski; N J Samani; D J van Veldhuisen; F Zannad; M Metra; A H Zwinderman
Journal:  Eur Heart J       Date:  2017-06-21       Impact factor: 29.983

8.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

9.  Gender differences in Egyptian patients hospitalized with heart failure: insights from the European Society of Cardiology Heart Failure Long-Term Registry.

Authors:  Mahmoud Hassanein; Magdy Abdelhamid; Bassem Ibrahim; Mohamed Sobhy; Gamela Nasr; Mohamed Wafaie Aboleineen; Ashraf Reda; Nabil Farag; Ahmed Elshazly; Tarek Khairy Abdeldayem; Fatma Elmesseiry; Hesham Boshra; Hesham Sobhy; Atef Elbahry; Amr Youssef; Medhat Ashmawy; Ahmed Abdelmoneim; Ayman Saleh; Yahya Elrakshy; Hamdy Ebeid
Journal:  ESC Heart Fail       Date:  2018-09-03

10.  Reasons for Guideline Nonadherence at Heart Failure Discharge.

Authors:  Lauren G Gilstrap; Lynne W Stevenson; Roy Small; Ron Parambi; Rose Hamershock; Jeffrey Greenberg; Christina Carr; Roya Ghazinouri; Lisa Rathman; Elizabeth Han; Mandeep R Mehra; Akshay S Desai
Journal:  J Am Heart Assoc       Date:  2018-08-07       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.